Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance

OBJECTIVES: Based on primary results from ORAL Surveillance, an event-driven clinical trial of risk-enriched patients, identify subpopulations with different relative risk (ie, ‘high-risk’ and ‘low-risk’) with tofacitinib versus tumour necrosis factor inhibitors (TNFi). METHODS: Patients with rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Lars Erik, Danese, Silvio, Yndestad, Arne, Wang, Cunshan, Nagy, Edward, Modesto, Irene, Rivas, Jose, Benda, Birgitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314011/
https://www.ncbi.nlm.nih.gov/pubmed/36931693
http://dx.doi.org/10.1136/ard-2022-223715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314011/
https://www.ncbi.nlm.nih.gov/pubmed/36931693
http://dx.doi.org/10.1136/ard-2022-223715

Ejemplares similares